Global Chronic Myeloid Leukemia Treatment Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Chronic Myeloid Leukemia Treatment Drugs market size was valued at US$ 784 million in 2024 and is forecast to a readjusted size of USD 1043 million by 2031 with a CAGR of 4.2% during review period.
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the adults and very rarely it occurs in children. Chronic myeloid leukemia usually begins after age 60. CML is develop slowly and treated with targeted cancer drugs such as tyrosine kinase inhibitors, chemotherapy or a bone marrow transplant. Recent advances in cancer treatments has drastically improved the survival rate for this type of leukemia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Chronic Myeloid Leukemia Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chronic Myeloid Leukemia Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chronic Myeloid Leukemia Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chronic Myeloid Leukemia Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chronic Myeloid Leukemia Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Myeloid Leukemia Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Myeloid Leukemia Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Takeda Pharmaceutical Company Limited, Innovent Biologics, Inc., Viatris Inc. (Mylan N.V.), Lupin, IL-YANG PHARM CO. LTD., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Chronic Myeloid Leukemia Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Myeloid Leukemia Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chronic Myeloid Leukemia Treatment Drugs, with price, sales quantity, revenue, and global market share of Chronic Myeloid Leukemia Treatment Drugs from 2020 to 2025.
Chapter 3, the Chronic Myeloid Leukemia Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Myeloid Leukemia Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Chronic Myeloid Leukemia Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chronic Myeloid Leukemia Treatment Drugs.
Chapter 14 and 15, to describe Chronic Myeloid Leukemia Treatment Drugs sales channel, distributors, customers, research findings and conclusion.
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the adults and very rarely it occurs in children. Chronic myeloid leukemia usually begins after age 60. CML is develop slowly and treated with targeted cancer drugs such as tyrosine kinase inhibitors, chemotherapy or a bone marrow transplant. Recent advances in cancer treatments has drastically improved the survival rate for this type of leukemia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Chronic Myeloid Leukemia Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chronic Myeloid Leukemia Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chronic Myeloid Leukemia Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chronic Myeloid Leukemia Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chronic Myeloid Leukemia Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Myeloid Leukemia Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Myeloid Leukemia Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Takeda Pharmaceutical Company Limited, Innovent Biologics, Inc., Viatris Inc. (Mylan N.V.), Lupin, IL-YANG PHARM CO. LTD., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Chronic Myeloid Leukemia Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Tablet
- Solution
- Capsule
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Teva Pharmaceutical Industries Ltd
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Innovent Biologics, Inc.
- Viatris Inc. (Mylan N.V.)
- Lupin
- IL-YANG PHARM CO. LTD.
- Million Health Pharmaceuticals
- Celon Labs
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chronic Myeloid Leukemia Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chronic Myeloid Leukemia Treatment Drugs, with price, sales quantity, revenue, and global market share of Chronic Myeloid Leukemia Treatment Drugs from 2020 to 2025.
Chapter 3, the Chronic Myeloid Leukemia Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Myeloid Leukemia Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Chronic Myeloid Leukemia Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chronic Myeloid Leukemia Treatment Drugs.
Chapter 14 and 15, to describe Chronic Myeloid Leukemia Treatment Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Tablet
1.3.3 Solution
1.3.4 Capsule
1.4 Market Analysis by Application
1.4.1 Overview: Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Chronic Myeloid Leukemia Treatment Drugs Market Size & Forecast
1.5.1 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (2020-2031)
1.5.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Teva Pharmaceutical Industries Ltd Details
2.1.2 Teva Pharmaceutical Industries Ltd Major Business
2.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.1.4 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.2 F. Hoffmann-La Roche Ltd.
2.2.1 F. Hoffmann-La Roche Ltd. Details
2.2.2 F. Hoffmann-La Roche Ltd. Major Business
2.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.2.4 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business
2.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.4.4 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.5 Pfizer Inc.
2.5.1 Pfizer Inc. Details
2.5.2 Pfizer Inc. Major Business
2.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.5.4 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Pfizer Inc. Recent Developments/Updates
2.6 Takeda Pharmaceutical Company Limited
2.6.1 Takeda Pharmaceutical Company Limited Details
2.6.2 Takeda Pharmaceutical Company Limited Major Business
2.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.6.4 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.7 Innovent Biologics, Inc.
2.7.1 Innovent Biologics, Inc. Details
2.7.2 Innovent Biologics, Inc. Major Business
2.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.7.4 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Innovent Biologics, Inc. Recent Developments/Updates
2.8 Viatris Inc. (Mylan N.V.)
2.8.1 Viatris Inc. (Mylan N.V.) Details
2.8.2 Viatris Inc. (Mylan N.V.) Major Business
2.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.8.4 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
2.9 Lupin
2.9.1 Lupin Details
2.9.2 Lupin Major Business
2.9.3 Lupin Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.9.4 Lupin Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Lupin Recent Developments/Updates
2.10 IL-YANG PHARM CO. LTD.
2.10.1 IL-YANG PHARM CO. LTD. Details
2.10.2 IL-YANG PHARM CO. LTD. Major Business
2.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.10.4 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 IL-YANG PHARM CO. LTD. Recent Developments/Updates
2.11 Million Health Pharmaceuticals
2.11.1 Million Health Pharmaceuticals Details
2.11.2 Million Health Pharmaceuticals Major Business
2.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.11.4 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Million Health Pharmaceuticals Recent Developments/Updates
2.12 Celon Labs
2.12.1 Celon Labs Details
2.12.2 Celon Labs Major Business
2.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.12.4 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Celon Labs Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS BY MANUFACTURER
3.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Manufacturer (2020-2025)
3.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Manufacturer (2020-2025)
3.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Chronic Myeloid Leukemia Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Chronic Myeloid Leukemia Treatment Drugs Manufacturer Market Share in 2024
3.4.3 Top 6 Chronic Myeloid Leukemia Treatment Drugs Manufacturer Market Share in 2024
3.5 Chronic Myeloid Leukemia Treatment Drugs Market: Overall Company Footprint Analysis
3.5.1 Chronic Myeloid Leukemia Treatment Drugs Market: Region Footprint
3.5.2 Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Type Footprint
3.5.3 Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Region
4.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2031)
4.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2031)
4.1.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Region (2020-2031)
4.2 North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.3 Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.4 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.5 South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.6 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
5.2 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type (2020-2031)
5.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
6.2 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application (2020-2031)
6.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
7.2 North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
7.3 North America Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
7.3.1 North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
7.3.2 North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
8.2 Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
8.3 Europe Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
8.3.1 Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
8.3.2 Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Market Size by Region
9.3.1 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
10.2 South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
10.3 South America Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
10.3.1 South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
10.3.2 South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
11.3.1 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Chronic Myeloid Leukemia Treatment Drugs Market Drivers
12.2 Chronic Myeloid Leukemia Treatment Drugs Market Restraints
12.3 Chronic Myeloid Leukemia Treatment Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Chronic Myeloid Leukemia Treatment Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Chronic Myeloid Leukemia Treatment Drugs
13.3 Chronic Myeloid Leukemia Treatment Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Chronic Myeloid Leukemia Treatment Drugs Typical Distributors
14.3 Chronic Myeloid Leukemia Treatment Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Tablet
1.3.3 Solution
1.3.4 Capsule
1.4 Market Analysis by Application
1.4.1 Overview: Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Chronic Myeloid Leukemia Treatment Drugs Market Size & Forecast
1.5.1 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (2020-2031)
1.5.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Teva Pharmaceutical Industries Ltd Details
2.1.2 Teva Pharmaceutical Industries Ltd Major Business
2.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.1.4 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.2 F. Hoffmann-La Roche Ltd.
2.2.1 F. Hoffmann-La Roche Ltd. Details
2.2.2 F. Hoffmann-La Roche Ltd. Major Business
2.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.2.4 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business
2.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.4.4 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.5 Pfizer Inc.
2.5.1 Pfizer Inc. Details
2.5.2 Pfizer Inc. Major Business
2.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.5.4 Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Pfizer Inc. Recent Developments/Updates
2.6 Takeda Pharmaceutical Company Limited
2.6.1 Takeda Pharmaceutical Company Limited Details
2.6.2 Takeda Pharmaceutical Company Limited Major Business
2.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.6.4 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.7 Innovent Biologics, Inc.
2.7.1 Innovent Biologics, Inc. Details
2.7.2 Innovent Biologics, Inc. Major Business
2.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.7.4 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Innovent Biologics, Inc. Recent Developments/Updates
2.8 Viatris Inc. (Mylan N.V.)
2.8.1 Viatris Inc. (Mylan N.V.) Details
2.8.2 Viatris Inc. (Mylan N.V.) Major Business
2.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.8.4 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
2.9 Lupin
2.9.1 Lupin Details
2.9.2 Lupin Major Business
2.9.3 Lupin Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.9.4 Lupin Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Lupin Recent Developments/Updates
2.10 IL-YANG PHARM CO. LTD.
2.10.1 IL-YANG PHARM CO. LTD. Details
2.10.2 IL-YANG PHARM CO. LTD. Major Business
2.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.10.4 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 IL-YANG PHARM CO. LTD. Recent Developments/Updates
2.11 Million Health Pharmaceuticals
2.11.1 Million Health Pharmaceuticals Details
2.11.2 Million Health Pharmaceuticals Major Business
2.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.11.4 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Million Health Pharmaceuticals Recent Developments/Updates
2.12 Celon Labs
2.12.1 Celon Labs Details
2.12.2 Celon Labs Major Business
2.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product and Services
2.12.4 Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Celon Labs Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHRONIC MYELOID LEUKEMIA TREATMENT DRUGS BY MANUFACTURER
3.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Manufacturer (2020-2025)
3.2 Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Manufacturer (2020-2025)
3.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Chronic Myeloid Leukemia Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Chronic Myeloid Leukemia Treatment Drugs Manufacturer Market Share in 2024
3.4.3 Top 6 Chronic Myeloid Leukemia Treatment Drugs Manufacturer Market Share in 2024
3.5 Chronic Myeloid Leukemia Treatment Drugs Market: Overall Company Footprint Analysis
3.5.1 Chronic Myeloid Leukemia Treatment Drugs Market: Region Footprint
3.5.2 Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Type Footprint
3.5.3 Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Chronic Myeloid Leukemia Treatment Drugs Market Size by Region
4.1.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2031)
4.1.2 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2031)
4.1.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Region (2020-2031)
4.2 North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.3 Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.4 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.5 South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
4.6 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
5.2 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type (2020-2031)
5.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
6.2 Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application (2020-2031)
6.3 Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
7.2 North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
7.3 North America Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
7.3.1 North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
7.3.2 North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
8.2 Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
8.3 Europe Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
8.3.1 Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
8.3.2 Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Market Size by Region
9.3.1 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
10.2 South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
10.3 South America Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
10.3.1 South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
10.3.2 South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Market Size by Country
11.3.1 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Chronic Myeloid Leukemia Treatment Drugs Market Drivers
12.2 Chronic Myeloid Leukemia Treatment Drugs Market Restraints
12.3 Chronic Myeloid Leukemia Treatment Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Chronic Myeloid Leukemia Treatment Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Chronic Myeloid Leukemia Treatment Drugs
13.3 Chronic Myeloid Leukemia Treatment Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Chronic Myeloid Leukemia Treatment Drugs Typical Distributors
14.3 Chronic Myeloid Leukemia Treatment Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceutical Industries Ltd Major Business
Table 5. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 6. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 8. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. F. Hoffmann-La Roche Ltd. Major Business
Table 10. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 11. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 16. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Company Major Business
Table 20. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 21. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Bristol-Myers Squibb Company Recent Developments/Updates
Table 23. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Inc. Major Business
Table 25. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 26. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Pfizer Inc. Recent Developments/Updates
Table 28. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 29. Takeda Pharmaceutical Company Limited Major Business
Table 30. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 31. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 33. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Innovent Biologics, Inc. Major Business
Table 35. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 36. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Innovent Biologics, Inc. Recent Developments/Updates
Table 38. Viatris Inc. (Mylan N.V.) Basic Information, Manufacturing Base and Competitors
Table 39. Viatris Inc. (Mylan N.V.) Major Business
Table 40. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 41. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
Table 43. Lupin Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Major Business
Table 45. Lupin Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 46. Lupin Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Lupin Recent Developments/Updates
Table 48. IL-YANG PHARM CO. LTD. Basic Information, Manufacturing Base and Competitors
Table 49. IL-YANG PHARM CO. LTD. Major Business
Table 50. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 51. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. IL-YANG PHARM CO. LTD. Recent Developments/Updates
Table 53. Million Health Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Million Health Pharmaceuticals Major Business
Table 55. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 56. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Million Health Pharmaceuticals Recent Developments/Updates
Table 58. Celon Labs Basic Information, Manufacturing Base and Competitors
Table 59. Celon Labs Major Business
Table 60. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 61. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Celon Labs Recent Developments/Updates
Table 63. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 64. Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 66. Market Position of Manufacturers in Chronic Myeloid Leukemia Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and Chronic Myeloid Leukemia Treatment Drugs Production Site of Key Manufacturer
Table 68. Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Type Footprint
Table 69. Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Application Footprint
Table 70. Chronic Myeloid Leukemia Treatment Drugs New Market Entrants and Barriers to Market Entry
Table 71. Chronic Myeloid Leukemia Treatment Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2025) & (K Units)
Table 74. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2026-2031) & (K Units)
Table 75. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Region (2020-2025) & (US$/Unit)
Table 78. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Region (2026-2031) & (US$/Unit)
Table 79. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 80. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 81. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2020-2025) & (US$/Unit)
Table 84. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2026-2031) & (US$/Unit)
Table 85. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 86. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 87. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2020-2025) & (US$/Unit)
Table 90. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2026-2031) & (US$/Unit)
Table 91. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 92. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 93. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 94. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 95. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 96. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 97. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 102. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 103. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 104. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 105. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 108. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 109. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 110. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 111. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2025) & (K Units)
Table 112. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2026-2031) & (K Units)
Table 113. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 116. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 117. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 118. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 119. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 120. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 121. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 124. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 125. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 128. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 129. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 131. Chronic Myeloid Leukemia Treatment Drugs Raw Material
Table 132. Key Manufacturers of Chronic Myeloid Leukemia Treatment Drugs Raw Materials
Table 133. Chronic Myeloid Leukemia Treatment Drugs Typical Distributors
Table 134. Chronic Myeloid Leukemia Treatment Drugs Typical Customers
Table 1. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceutical Industries Ltd Major Business
Table 5. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 6. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 8. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. F. Hoffmann-La Roche Ltd. Major Business
Table 10. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 11. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 16. Novartis AG Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Company Major Business
Table 20. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 21. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Bristol-Myers Squibb Company Recent Developments/Updates
Table 23. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Inc. Major Business
Table 25. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 26. Pfizer Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Pfizer Inc. Recent Developments/Updates
Table 28. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 29. Takeda Pharmaceutical Company Limited Major Business
Table 30. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 31. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 33. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Innovent Biologics, Inc. Major Business
Table 35. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 36. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Innovent Biologics, Inc. Recent Developments/Updates
Table 38. Viatris Inc. (Mylan N.V.) Basic Information, Manufacturing Base and Competitors
Table 39. Viatris Inc. (Mylan N.V.) Major Business
Table 40. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 41. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
Table 43. Lupin Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Major Business
Table 45. Lupin Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 46. Lupin Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Lupin Recent Developments/Updates
Table 48. IL-YANG PHARM CO. LTD. Basic Information, Manufacturing Base and Competitors
Table 49. IL-YANG PHARM CO. LTD. Major Business
Table 50. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 51. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. IL-YANG PHARM CO. LTD. Recent Developments/Updates
Table 53. Million Health Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Million Health Pharmaceuticals Major Business
Table 55. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 56. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Million Health Pharmaceuticals Recent Developments/Updates
Table 58. Celon Labs Basic Information, Manufacturing Base and Competitors
Table 59. Celon Labs Major Business
Table 60. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Product and Services
Table 61. Celon Labs Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Celon Labs Recent Developments/Updates
Table 63. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 64. Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 66. Market Position of Manufacturers in Chronic Myeloid Leukemia Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and Chronic Myeloid Leukemia Treatment Drugs Production Site of Key Manufacturer
Table 68. Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Type Footprint
Table 69. Chronic Myeloid Leukemia Treatment Drugs Market: Company Product Application Footprint
Table 70. Chronic Myeloid Leukemia Treatment Drugs New Market Entrants and Barriers to Market Entry
Table 71. Chronic Myeloid Leukemia Treatment Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2025) & (K Units)
Table 74. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2026-2031) & (K Units)
Table 75. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Region (2020-2025) & (US$/Unit)
Table 78. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Region (2026-2031) & (US$/Unit)
Table 79. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 80. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 81. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2020-2025) & (US$/Unit)
Table 84. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2026-2031) & (US$/Unit)
Table 85. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 86. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 87. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2020-2025) & (US$/Unit)
Table 90. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2026-2031) & (US$/Unit)
Table 91. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 92. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 93. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 94. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 95. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 96. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 97. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 100. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 101. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 102. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 103. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 104. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 105. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 108. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 109. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 110. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 111. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2020-2025) & (K Units)
Table 112. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Region (2026-2031) & (K Units)
Table 113. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 116. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 117. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 118. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 119. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 120. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 121. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2020-2025) & (K Units)
Table 124. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Type (2026-2031) & (K Units)
Table 125. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2020-2025) & (K Units)
Table 128. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity by Country (2026-2031) & (K Units)
Table 129. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Country (2026-2031) & (USD Million)
Table 131. Chronic Myeloid Leukemia Treatment Drugs Raw Material
Table 132. Key Manufacturers of Chronic Myeloid Leukemia Treatment Drugs Raw Materials
Table 133. Chronic Myeloid Leukemia Treatment Drugs Typical Distributors
Table 134. Chronic Myeloid Leukemia Treatment Drugs Typical Customers
LIST OF FIGURES
Figure 1. Chronic Myeloid Leukemia Treatment Drugs Picture
Figure 2. Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Type in 2024
Figure 4. Tablet Examples
Figure 5. Solution Examples
Figure 6. Capsule Examples
Figure 7. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Application in 2024
Figure 9. Hospital Pharmacies Examples
Figure 10. Retail Pharmacies Examples
Figure 11. Online Pharmacies Examples
Figure 12. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Chronic Myeloid Leukemia Treatment Drugs Price (2020-2031) & (US$/Unit)
Figure 16. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Chronic Myeloid Leukemia Treatment Drugs by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Chronic Myeloid Leukemia Treatment Drugs Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Chronic Myeloid Leukemia Treatment Drugs Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2020-2031) & (US$/Unit)
Figure 31. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Application (2020-2031)
Figure 33. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 46. France Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 54. China Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 57. India Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 74. Chronic Myeloid Leukemia Treatment Drugs Market Drivers
Figure 75. Chronic Myeloid Leukemia Treatment Drugs Market Restraints
Figure 76. Chronic Myeloid Leukemia Treatment Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Chronic Myeloid Leukemia Treatment Drugs in 2024
Figure 79. Manufacturing Process Analysis of Chronic Myeloid Leukemia Treatment Drugs
Figure 80. Chronic Myeloid Leukemia Treatment Drugs Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Chronic Myeloid Leukemia Treatment Drugs Picture
Figure 2. Global Chronic Myeloid Leukemia Treatment Drugs Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Type in 2024
Figure 4. Tablet Examples
Figure 5. Solution Examples
Figure 6. Capsule Examples
Figure 7. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Application in 2024
Figure 9. Hospital Pharmacies Examples
Figure 10. Retail Pharmacies Examples
Figure 11. Online Pharmacies Examples
Figure 12. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Chronic Myeloid Leukemia Treatment Drugs Price (2020-2031) & (US$/Unit)
Figure 16. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Chronic Myeloid Leukemia Treatment Drugs by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Chronic Myeloid Leukemia Treatment Drugs Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Chronic Myeloid Leukemia Treatment Drugs Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Type (2020-2031) & (US$/Unit)
Figure 31. Global Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Chronic Myeloid Leukemia Treatment Drugs Revenue Market Share by Application (2020-2031)
Figure 33. Global Chronic Myeloid Leukemia Treatment Drugs Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 46. France Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Region (2020-2031)
Figure 54. China Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 57. India Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Chronic Myeloid Leukemia Treatment Drugs Consumption Value (2020-2031) & (USD Million)
Figure 74. Chronic Myeloid Leukemia Treatment Drugs Market Drivers
Figure 75. Chronic Myeloid Leukemia Treatment Drugs Market Restraints
Figure 76. Chronic Myeloid Leukemia Treatment Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Chronic Myeloid Leukemia Treatment Drugs in 2024
Figure 79. Manufacturing Process Analysis of Chronic Myeloid Leukemia Treatment Drugs
Figure 80. Chronic Myeloid Leukemia Treatment Drugs Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
